Moberg Pharma AB (publ) (STO:MOB)
Sweden
· Delayed Price · Currency is SEK 11.48
-0.52 (-4.33%)
Apr 28, 2026, 5:29 PM CET
Moberg Pharma AB Employees
Moberg Pharma AB had 10 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
2.71M SEK
Profits / Employee
-5.45M SEK
Market Cap
564.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cinclus Pharma Holding AB | 21 |
| Nanexa AB | 15 |
| Enzymatica AB | 20 |
| Orexo AB | 74 |
| Dicot Pharma AB | 4 |
| EQL Pharma AB | 55 |
| Klaria Pharma Holding AB (publ.) | 4 |
| Cereno Scientific AB | 10 |
Moberg Pharma AB News
- 6 months ago - Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential - PRNewsWire
- 1 year ago - Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU - PRNewsWire
- 1 year ago - Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients - PRNewsWire
- 2 years ago - Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98% - PRNewsWire